Major Depression (in Remission)
Conditions
Brief summary
This research will investigate the neuropsychological mechanisms underlying the eight-week Mindfulness-based Cognitive Therapy (MBCT) programme. Participants in remission from depression will be seen pre- and post-MBCT to assess the underlying neuropsychological mechanisms. All will be followed-up over 12 months to assess the relationship of these neuropsychological changes with relapse risk. The research will focus primarily on changes in self-compassion, rumination, attention and structural brain changes, with secondary focus on other mechanisms of emotional processing and memory.
Detailed description
There will be three groups in total. * The first group will take 36 participants in remission from major depression (rMDD) through the 8 week MBCT program. * A control group of 36 rMDD participants will not receive the intervention. * A group of never depressed healthy control participants will also be recruited. Research visits for participants not undergoing MBCT will be separated by an 8 week gap. All participants will be seen before and after the 8 weeks for completion of neuropsychological assessments and questionnaires. rMDD participants will be followed up over the following 12 months to identify any predictors of relapse.
Interventions
BEHAVIORALMindfulness-based Cognitive Therapy
MBCT: Mindfulness-based Cognitive Therapy is an 8 week group-based programme consisting of approximately 12 participants per group. There is also a full one day of practice around week 6. MBCT was initially designed for individuals in remission from depression and at risk of relapsing. The intervention is a mix of mindfulness meditation, cognitive behavioural therapy exercises and psychoeducation. MBCT has been shown to be effective in reducing relapse risk over 12 months.
Sponsors
University of Manchester
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
Participants with remitted depression (rMDD): * At least two previous episodes of DSM-IV major depression in adulthood, diagnosed using the Mini International Neuropsychiatric Interview (M.I.N.I). * Full or partial remission for at least three months with two depressive episodes within the last five years. * A score of less than or equal to 12 on the Montgomery Asberg Depression Rating Scale (MADRS) mood assessment. * If on medication, no recent or planned major changes Healthy volunteers: * In good psychological health screened with the M.I.N.I All participants: * in good physical health (to reduce risk of confounding physical health problems). * sufficiently fluent in English to ensure valid understanding and completion of the tasks. * minimum I.Q level of 80 to ensure sufficient understanding of the neurocognitive tasks administered. * colour vision and acuity within normal/corrected to normal limits.
Exclusion criteria
* Any current mental health diagnosis (DSM-IV diagnosis including current major depression, bipolar disorder, psychosis, Obsessive Compulsive Disorder (OCD), substance abuse or dependence, eating disorders) * Physical health or neurological disorders that might interfere with the interpretation of the tasks, including a history of significant head injury. * In addition healthy volunteers will be without a history mental health disorders (DSM-IV) * Current or previous experience of mindfulness-based treatments or extensive cognitive behavioural treatment, or planned participation in psychological treatments during the key time for the study (between pre and post visits). * Planned major alteration in drug treatment for depression between pre and post visits.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in self-compassion following MBCT measured by both neuropsychological and self-report measures | measured at baseline and post intervention (8 weeks post baseline) and at each follow-up visit (3 in total) | Two neuropsychological measures of self-compassion have been developed and will be administerat baseline and after MBCT/8 week gap (8 weeks post baseline). Self-report questionnaires will be administered before and after MBCT/8 week gap and at subsequent follow-up visits (3, 6, 12 months). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in levels of rumination following MBCT measured through both neuropsychological and self-report measures | measured at baseline and after the intervention/8 week gap (8 weeks post baseline) and at each follow-up visit (3 in total) | One neuropsychological measure of rumination has been developed and will be administered at baseline and immediately after MBCT/8 week gap (8 weeks post baseline). Self-report questionnaires will be administered at baseline and after MBCT/8 week gap (8 weeks post baseline) and at subsequent follow-up visits (3,6,12 months). |
| Changes in attention regulation following MBCT | measured at baseline and after the intervention/8 week gap (8 weeks post baseline) | — |
| Changes in brain structure following MBCT | measured at baseline and after the intervention (8 weeks post baseline) | — |
Other
| Measure | Time frame | Description |
|---|---|---|
| Changes in emotional processing | measured at baseline and after the intervention/8 week gap (8 weeks post baseline) | Other neuropsychological assessments of emotional processing (face emotion recognition, memory, cognitive flexibility) will be assessed at baseline and after MBCT/8 week gap (8 weeks post baseline). |
Countries
United Kingdom
Outcome results
None listed